10x Genomics (TXG) Competitors $14.04 +0.43 (+3.16%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends TXG vs. CTKB, LAB, PACB, EYPT, QTRX, NAUT, SEER, AKYA, HBIO, and PREShould you be buying 10x Genomics stock or one of its competitors? The main competitors of 10x Genomics include Cytek Biosciences (CTKB), Standard BioTools (LAB), Pacific Biosciences of California (PACB), EyePoint Pharmaceuticals (EYPT), Quanterix (QTRX), Nautilus Biotechnology (NAUT), Seer (SEER), Akoya Biosciences (AKYA), Harvard Bioscience (HBIO), and Prenetics Global (PRE). These companies are all part of the "analytical instruments" industry. 10x Genomics vs. Cytek Biosciences Standard BioTools Pacific Biosciences of California EyePoint Pharmaceuticals Quanterix Nautilus Biotechnology Seer Akoya Biosciences Harvard Bioscience Prenetics Global 10x Genomics (NASDAQ:TXG) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends. Does the MarketBeat Community favor TXG or CTKB? 10x Genomics received 34 more outperform votes than Cytek Biosciences when rated by MarketBeat users. Likewise, 52.94% of users gave 10x Genomics an outperform vote while only 45.45% of users gave Cytek Biosciences an outperform vote. CompanyUnderperformOutperform10x GenomicsOutperform Votes5452.94% Underperform Votes4847.06% Cytek BiosciencesOutperform Votes2045.45% Underperform Votes2454.55% Is TXG or CTKB more profitable? Cytek Biosciences has a net margin of -5.05% compared to 10x Genomics' net margin of -28.93%. Cytek Biosciences' return on equity of -2.58% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-28.93% -25.07% -19.41% Cytek Biosciences -5.05%-2.58%-2.05% Do insiders and institutionals hold more shares of TXG or CTKB? 84.7% of 10x Genomics shares are held by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are held by institutional investors. 10.0% of 10x Genomics shares are held by insiders. Comparatively, 9.6% of Cytek Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has better earnings and valuation, TXG or CTKB? Cytek Biosciences has lower revenue, but higher earnings than 10x Genomics. Cytek Biosciences is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$629.74M2.70-$255.10M-$1.53-9.18Cytek Biosciences$201.21M4.05-$12.15M-$0.08-79.00 Which has more volatility and risk, TXG or CTKB? 10x Genomics has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500. Comparatively, Cytek Biosciences has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Do analysts prefer TXG or CTKB? 10x Genomics currently has a consensus price target of $25.14, indicating a potential upside of 79.08%. Cytek Biosciences has a consensus price target of $9.25, indicating a potential upside of 46.36%. Given 10x Genomics' higher possible upside, analysts plainly believe 10x Genomics is more favorable than Cytek Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 1 Sell rating(s) 7 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.53Cytek Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to TXG or CTKB? In the previous week, 10x Genomics and 10x Genomics both had 2 articles in the media. Cytek Biosciences' average media sentiment score of 1.04 beat 10x Genomics' score of 0.32 indicating that Cytek Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cytek Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Summary10x Genomics beats Cytek Biosciences on 10 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get 10x Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TXG vs. The Competition Export to ExcelMetric10x GenomicsAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.70B$5.42B$5.07B$9.08BDividend YieldN/A0.42%4.87%4.21%P/E Ratio-9.1825.1899.0517.15Price / Sales2.704.291,121.17116.80Price / CashN/A44.4541.5237.88Price / Book2.262.204.754.78Net Income-$255.10M$2.05M$119.33M$225.60M7 Day Performance-1.16%-2.70%-1.86%-1.23%1 Month Performance4.92%-2.89%11.40%3.07%1 Year Performance-75.04%-28.70%30.26%16.48% 10x Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TXG10x Genomics4.4223 of 5 stars$14.04+3.2%$25.14+79.1%-74.3%$1.70B$629.74M-9.181,259CTKBCytek Biosciences2.3488 of 5 stars$6.45+3.9%$9.25+43.4%-32.3%$830.83M$201.21M-77.63500Positive NewsLABStandard BioTools3.2542 of 5 stars$2.06+7.9%$2.88+39.6%+3.6%$766.85M$155.90M-2.69620News CoveragePositive NewsGap DownPACBPacific Biosciences of California1.5546 of 5 stars$2.05+4.6%$2.95+44.1%-79.8%$561.41M$200.52M-1.46730EYPTEyePoint Pharmaceuticals1.9424 of 5 stars$7.43-0.4%$25.71+246.1%-63.3%$507.11M$45.71M-3.79120News CoveragePositive NewsQTRXQuanterix2.0157 of 5 stars$10.73+0.5%$23.25+116.7%-60.9%$411.82M$122.37M-10.09460NAUTNautilus Biotechnology1.634 of 5 stars$2.00+2.6%$3.58+79.2%-41.3%$251.13MN/A-3.48130SEERSeer1.6657 of 5 stars$2.48+0.4%$3.00+21.0%+38.3%$146.25M$16.66M-1.90160AKYAAkoya Biosciences1.9076 of 5 stars$2.36+4.0%$5.43+130.0%-47.1%$116.97M$86.82M-1.9290HBIOHarvard Bioscience1.2863 of 5 stars$2.12-1.9%N/A-57.8%$92.47M$97.73M-6.55490PREPrenetics Global1.9633 of 5 stars$5.94flat$9.00+51.5%+14.9%$54.27M$25.56M-1.491Gap Up Related Companies and Tools Related Companies Cytek Biosciences Alternatives Standard BioTools Alternatives Pacific Biosciences of California Alternatives EyePoint Pharmaceuticals Alternatives Quanterix Alternatives Nautilus Biotechnology Alternatives Seer Alternatives Akoya Biosciences Alternatives Harvard Bioscience Alternatives Prenetics Global Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TXG) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 10x Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 10x Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXG Stock Alerts